New ‘zero-contrast’ TAVR technique shows promise in pilot study

No contrast transcatheter aortic valve replacement

TAVR with zero-contrast strategy using the self-expandable Evolut R/Pro THV in patients with chronic kidney disease. Images courtesy of Freire et al. and Frontiers in Cardiovascular Medicine.

Researchers think this new technique could be beneficial for patients presenting with both severe symptomatic aortic stenosis and chronic kidney disease.